logo
Products
Services
Resources
Selection Guides
About
PE/XFD610 Anti-human CD25 Antibody
7G7B6
The 7G7B6 monoclonal antibody recognizes human CD25, a 55 kD glycoprotein often located on the surface of oligodendrocytes, T cells, B cells and thymocytes. In certain organisms, CD25 negatively regulates defense response to virus, downregulates inflammatory response and positively regulates activated T cell proliferation. Additionally, it is involved with critical cellular pathways, for instance, the interleukin-2-mediated signaling pathway, cell surface receptor signaling pathway and cytokine-mediated signaling pathway. From a research standpoint, it is of biological interest due to its association with important macromolecules/ligands like IL-2. CD25 is a very popular antibody target, with over 40000 publications in the last decade. CD25 is vital to immunology research, often serving as a phenotypic marker for differentiating cell types in flow cytometric applications. This antibody was purified through affinity chromatography and conjugated to PE/XFD610 (ex/em = 567/627 nm). XFD610 is manufactured by AAT Bioquest, and it has a chemical structure similar to that of Alexa Fluor® 610 (Alexa Fluor® is the trademark of Thermo Fisher). It is compatible with the 561 nm laser and 610/20 nm bandpass filter (for example, as in the BD FACSAria™ Fusion).
product image
CatalogSize
Price
Quantity
102511P025 tests
Price
102511P1100 tests
Price
102511P2500 tests
Price
 
Antibody properties

Other namesIL-2Rα, p55, TAC antigen
Clone7G7B6
HostMouse
IsotypeIgG2a
ReactivityHuman
Spectral properties

Extinction coefficient (cm -1 M -1)
1960000
Excitation (nm)565
Emission (nm)627
Usage and storage

Intended useResearch Use Only (RUO)
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on August 21, 2026